Summary
Fluorescence-guided surgery (FGS) uses near-infrared (NIR) sensors to detect and display fluorescent biomarkers indicating the exact location of tumors. But the current cameras and monitors force surgeons to match the images to the body via subjective comparisons. This long, error-prone process reduces the accuracy, and increases operating times and cost. This is a critical problem in cancer surgery where complete tumor removal is key to prevent recurrence, e.g. a yearly incidence of
Unfold all
/
Fold all
More information & hyperlinks
| Web resources: | https://cordis.europa.eu/project/id/190144382 |
| Start date: | 01-04-2023 |
| End date: | 31-03-2025 |
| Total budget - Public funding: | 3 514 695,00 Euro - 2 458 000,00 Euro |
Cordis data
Original description
Fluorescence-guided surgery (FGS) uses near-infrared (NIR) sensors to detect and display fluorescent biomarkers indicating the exact location of tumors. But the current cameras and monitors force surgeons to match the images to the body via subjective comparisons. This long, error-prone process reduces the accuracy, and increases operating times and cost. This is a critical problem in cancer surgery where complete tumor removal is key to prevent recurrence, e.g. a yearly incidence ofStatus
SIGNEDCall topic
HORIZON-EIC-2022-ACCELERATOROPEN-01Update Date
31-07-2023
Images
No images available.
Geographical location(s)
